@article {Amritphale2021.11.13.21266306, author = {Nupur Amritphale and Amod Amritphale and Deepa Vasireddy and Mansi Batra and Mukul Sehgal and David Gremse}, title = {Age Based Trends for Unplanned Pediatric Rehospitalizations in the United States}, elocation-id = {2021.11.13.21266306}, year = {2021}, doi = {10.1101/2021.11.13.21266306}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {BACKGROUND AND OBJECTIVES Hospital readmission rate helps to highlight the effectiveness of post-discharge care. There remains a paucity of plausible age based categorization especially for ages below one year for hospital readmission rates.METHODS Data from 2017 Healthcare cost and utilization project National readmissions database was analyzed for ages 0-18 years. Logistic regression analysis was performed to identify predictors for unplanned early readmissions.RESULTS We identified 5,529,389 inpatient pediatric encounters which were further divided into age group cohorts. The overall rate of readmissions was identified at 3.2\%. Beyond infancy, the readmission rate was found to be 6.7\%. Across all age groups, the major predictors of unplanned readmission were cancers, diseases affecting transplant recipients and sickle cell patients. It was determined that reflux, milk protein allergy, hepatitis and inflammatory bowel diseases were significant comorbidities leading to readmission. Anxiety, depression and suicidal ideation depicted higher readmission rates in those older than 13 years. Across ages 1-4 yrs, dehydration, asthma and bronchitis were negative predictors of unplanned readmission.CONCLUSIONS Thirty-day unplanned readmissions remain a problem leading to billions of tax-payer-dollars lost per annum. Effective strategies for mandatory outpatient follow-up may help the financial aspect of care while also enhancing the quality of care.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Publicly available data from Healthcare Utilization Project. Can be obtained from link https://www.hcup-us.ahrq.gov/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.}, URL = {https://www.medrxiv.org/content/early/2021/11/14/2021.11.13.21266306}, eprint = {https://www.medrxiv.org/content/early/2021/11/14/2021.11.13.21266306.full.pdf}, journal = {medRxiv} }